S&P/ASX 200 Index (ASX: XJO) shares are up 0.16% to 8,810.5 points on Monday.
Among the 11 market sectors, energy is in the lead today, up 1.9%.
The technology sector is the laggard, down 1.1%.
Let’s check out some new ratings on three ASX 200 shares.
Wisetech Global Ltd (ASX: WTC)
The Wisetech share price is $33.88, down 3.1% today and down 71% over 12 months.
Bell Potter has a buy rating on this ASX 200 tech share with a 12-month target price of $71.75.
Analyst Chris Savage said:
There has been a tech rally of sorts on the ASX over the past couple of months and this has been led by some of the large cap names including Pro Medicus Ltd (ASX: PME), Block CDI (ASX: XYZ) and Life360 Inc (ASX: 360).
One large cap which has not rallied, however, is WiseTech and this is likely due to a number of factors including further negative press reports around founder and Chief Innovation Officer Richard White, concern around the potential future loss of key customer DSV and risk around both the FY26 result and FY27 guidance and whether each meets market expectations.
In our view, however, these negatives will start to dissipate over the coming months and indeed have already commenced with
the appointment earlier this month of Raelene Murphy to Chair which we regard as a positive move.
Sigma Healthcare Ltd (ASX: SIG)
The Sigma Healthcare share price is $2.94, up 0.2% today and up 7% over 12 months.
Bell Potter has a hold rating on this ASX 200 healthcare share with a price target of $3.
Analyst John Hester said:
… investment metrics for SIG are not sufficiently attractive to warrant a Buy rating, particularly with a single payer (the Federal Government) representing a disproportionate level of group revenue.
The Government’s propensity to alter funding arrangements on short notice with little industry consultation should elevate the risk rating on SIG.
Commonwealth Bank of Australia (ASX: CBA)
CBA shares are $172.73 apiece, up 0.6% today and down 3% over 12 months.
Morgans has a sell rating on CBA shares and just reduced its 12-month target from $119.40 to $117.63.
Analyst Nathan Lead said:
We make updates to our forecasts ahead of the FY26 result in August. Net result is 1-2% downgrades to FY27-28F EPS.
Sell retained, given stretched valuation metrics remain implied in the share price (c.26x PER, 3.7x PBV, 2.9% cash yield).
The post Buy, hold, sell: Sigma Healthcare, Wisetech Global, CBA shares appeared first on The Motley Fool Australia.
Should you invest $1,000 in Commonwealth Bank Of Australia right now?
Before you buy Commonwealth Bank Of Australia shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Commonwealth Bank Of Australia wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys…
* Returns as of 16 June 2026
.custom-cta-button p {
margin-bottom: 0 !important;
}
More reading
- Why WiseTech shares could rocket 100%
- 5 things to watch on the ASX 200 on Monday
- If I invest $10,000 in Westpac shares, how much passive income will I receive in 2027?
- Buy, hold, sell: BHP, CBA, and Rio Tinto shares
- How to make $50,000 of passive income from ASX shares like CBA
Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Block, Life360, and WiseTech Global. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended Life360 and WiseTech Global. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.